♫musicjinni

2021 Urology CME Series: Prostate Cancer

video thumbnail
May 4, 2021: "Treatment Options for Localized Prostate Cancer," Michael Leapman, MD, Assistant Professor of Urology; Clinical
Program Leader, Prostate & Urologic Cancers Program, Yale
Cancer Center
; "Prostate Cancer Diagnosis and Risk Stratification,"
Preston Sprenkle, MD, Associate Professor of Urology; Division
Chief, Division of Urology at VA Connecticut Healthcare System;
Director, Urology Research Fellowship; Director, Urologic
Oncology Clinical Fellowship Program

2021 Urology CME Series: Prostate Cancer

Treatment Across the Prostate Cancer Continuum for Primary Care Clinician

Prostate Cancer Biomarkers and Their Role in the MRI Era | Urology Grand Rounds

Prostate Cancer Screening and Treatment Options

Changing the Treatment Story With Hormonal Therapy in Prostate Cancer

AUA Guidelines on Advanced Prostate Cancer Webcast (2023)

Advances in ADT: A Guide for Urologists and APPs

Prostate Cancer Diagnosis Webcast (2023)

Vitamin D and Prostate Cancer

Update on prostate cancer screening guidelines

Modern Treatment Approaches to Prostate Cancer

Comorbid Conditions in the Patient with Advanced Prostate Cancer

2023 Updates in Prostate Imaging with Pathology Correlation - A Video CME Teaching Activity

393 - Prostate cancer

CMEs in Oncology to strengthen your practice | Medical Learning Hub

Live webinars on Breast Cancer and Prostate Cancer | Continuous Medical Education (CME) | MLH

1.21.22 Resident didactic: Advanced prostate cancer - Principles and AUA Guideline

Prostate Cancer Risk Reduction - EMPIRE Urology Lecture Series

Health Equities and Variations in Advanced Prostate Cancer Care

Episode 41: Hot Topics Mini-series - Clinical decision-making in Prostate Cancer

Weill Cornell Urology - Dr. Christopher E. Barbieri: What Causes Prostate Cancer?

Metastatic Hormone Sensitive Prostate Cancer: Expert Guidance for Urologists

The Changing Face of Advanced Prostate Cancer (2024)

MRI of Prostate Cancer by Russell N. Low, M.D.

Genetic Testing in Prostate Cancer: Considerations for Urologists and Their Patients

Decision making in Prostate Cancer - Mirrors of Medicine session BAU2013

Operationalizing Checkpoint Inhibitors in Urologic Practice Webcast (2022)

Tom Guzzo, MD, MPH - Urologist, Penn Medicine

Prostate Cancer A Year in Review and the Year to Come

Chemotherapy & Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists & APPs

Disclaimer DMCA